Centre for Kidney Research (CKR), Kids Research Institute (KRI), The Children's Hospital at Westmead (CHW), NSW, Australia.
Centre for Transplant and Renal Research (CTRR), Westmead Institute for Medical Research (WIMR), Westmead, NSW, Australia.
Transplantation. 2020 Jul;104(7):1385-1395. doi: 10.1097/TP.0000000000003173.
Tolerance induced in stringent animal transplant models using donor-specific transfusions (DST) has previously required additional immunological manipulation. Here, we demonstrate a dominant skin-allograft tolerance model induced by a single DST across an major histocompatibility class I mismatch in an unmanipulated B6 host.
C57BL/6 (H-2) (B6) mice were injected intravenously with splenocytes from B6.C.H-2 (H-2k) (bm1) or F1 (B6 × bm1) mice before skin transplantation. Mice were transplanted 7 days postinjection with donor (bm1 or F1) and third-party B10.BR (H-2) skin grafts.
B6 hosts acutely rejected skin grafts from B6.C.H-2 (bm1) and F1 (B6 × bm1) mice. A single transfusion of F1 splenocytes into B6 mice without any additional immune modulation led to permanent acceptance of F1 skin grafts. This graft acceptance was associated with persistence of donor cells long-term in vivo. The more rapid removal of DST bm1 cells than F1 cells was reduced by natural killer-cell depletion. Tolerant grafts survived an in vivo challenge with naive splenocytes. Both CD4CD25 and CD4CD25 T cells from F1 DST treated B6 mice suppressed alloproliferation in vitro. Tolerance was associated with expansion of peripheral Foxp3CD4CD25 regulatory T cells (Treg) and increased forkhead box P3 (Foxp3) expression in tolerant grafts. In tolerant mice, Foxp3 Treg arises from the proliferation of indirectly activated natural Foxp3 Treg (nTreg) and depletion of Foxp3 Treg abrogates skin-graft tolerance.
This study demonstrates that the persistence of transfused semiallogeneic donor cells mismatched at major histocompatibility class I can enhance tolerance to subsequent skin allografts through indirectly expanded nTreg leading to dominant tolerance without additional immunological manipulation.
在严格的动物移植模型中,通过供体特异性输血(DST)诱导的耐受以前需要额外的免疫操作。在这里,我们在未经处理的 B6 宿主中,通过单次 DST 在主要组织相容性复合体 I 不匹配的情况下,展示了一种单一的皮肤同种异体移植物耐受模型。
C57BL/6(H-2)(B6)小鼠在静脉内注射来自 B6.C.H-2(H-2k)(bm1)或 F1(B6×bm1)小鼠的脾细胞,然后进行皮肤移植。在注射后 7 天,将供体(bm1 或 F1)和第三方 B10.BR(H-2)皮肤移植物移植到小鼠体内。
B6 宿主急性排斥 B6.C.H-2(bm1)和 F1(B6×bm1)小鼠的皮肤移植物。未经任何额外免疫调节,单次输注 F1 脾细胞可导致 F1 皮肤移植物的永久接受。这种移植物接受与供体细胞在体内长期存在有关。通过自然杀伤细胞耗竭,减少了 F1 细胞比 DST bm1 细胞更快的清除。耐受的移植物在体内挑战用幼稚脾细胞时存活下来。来自 F1 DST 处理的 B6 小鼠的 CD4CD25 和 CD4CD25 T 细胞均可在体外抑制同种异体增殖。耐受与外周 Foxp3CD4CD25 调节性 T 细胞(Treg)的扩张和耐受移植物中叉头框 P3(Foxp3)表达的增加有关。在耐受的小鼠中,Foxp3 Treg 来自间接激活的天然 Foxp3 Treg(nTreg)的增殖,Foxp3 Treg 的耗竭可破坏皮肤移植物的耐受性。
本研究表明,主要组织相容性复合体 I 不匹配的输注半同种异体供体细胞的持续存在可以通过间接扩增 nTreg 增强对随后的皮肤同种异体移植物的耐受,从而无需额外的免疫操作即可导致显性耐受。